12-132659414-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006231.4(POLE):​c.3156G>A​(p.Thr1052Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.464 in 1,613,846 control chromosomes in the GnomAD database, including 179,148 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T1052T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.54 ( 23133 hom., cov: 33)
Exomes 𝑓: 0.46 ( 156015 hom. )

Consequence

POLE
NM_006231.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: -1.20

Publications

32 publications found
Variant links:
Genes affected
POLE (HGNC:9177): (DNA polymerase epsilon, catalytic subunit) This gene encodes the catalytic subunit of DNA polymerase epsilon. The enzyme is involved in DNA repair and chromosomal DNA replication. Mutations in this gene have been associated with colorectal cancer 12 and facial dysmorphism, immunodeficiency, livedo, and short stature. [provided by RefSeq, Sep 2013]
POLE Gene-Disease associations (from GenCC):
  • POLE-related polyposis and colorectal cancer syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • colorectal cancer, susceptibility to, 12
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • facial dysmorphism-immunodeficiency-livedo-short stature syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • IMAGe syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Polymerase proofreading-related adenomatous polyposis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 12-132659414-C-T is Benign according to our data. Variant chr12-132659414-C-T is described in ClinVar as Benign. ClinVar VariationId is 380212.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.2 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.709 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006231.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLE
NM_006231.4
MANE Select
c.3156G>Ap.Thr1052Thr
synonymous
Exon 26 of 49NP_006222.2Q07864

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLE
ENST00000320574.10
TSL:1 MANE Select
c.3156G>Ap.Thr1052Thr
synonymous
Exon 26 of 49ENSP00000322570.5Q07864
POLE
ENST00000535270.5
TSL:1
c.3075G>Ap.Thr1025Thr
synonymous
Exon 25 of 48ENSP00000445753.1F5H1D6
POLE
ENST00000537064.5
TSL:1
n.*2203G>A
non_coding_transcript_exon
Exon 26 of 49ENSP00000442578.1F5H7E4

Frequencies

GnomAD3 genomes
AF:
0.535
AC:
81396
AN:
152042
Hom.:
23086
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.715
Gnomad AMI
AF:
0.324
Gnomad AMR
AF:
0.555
Gnomad ASJ
AF:
0.383
Gnomad EAS
AF:
0.701
Gnomad SAS
AF:
0.558
Gnomad FIN
AF:
0.433
Gnomad MID
AF:
0.500
Gnomad NFE
AF:
0.434
Gnomad OTH
AF:
0.528
GnomAD2 exomes
AF:
0.503
AC:
126545
AN:
251400
AF XY:
0.496
show subpopulations
Gnomad AFR exome
AF:
0.716
Gnomad AMR exome
AF:
0.578
Gnomad ASJ exome
AF:
0.390
Gnomad EAS exome
AF:
0.705
Gnomad FIN exome
AF:
0.430
Gnomad NFE exome
AF:
0.431
Gnomad OTH exome
AF:
0.476
GnomAD4 exome
AF:
0.457
AC:
667281
AN:
1461686
Hom.:
156015
Cov.:
47
AF XY:
0.459
AC XY:
333403
AN XY:
727144
show subpopulations
African (AFR)
AF:
0.716
AC:
23959
AN:
33476
American (AMR)
AF:
0.572
AC:
25579
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.390
AC:
10185
AN:
26134
East Asian (EAS)
AF:
0.697
AC:
27683
AN:
39700
South Asian (SAS)
AF:
0.546
AC:
47106
AN:
86254
European-Finnish (FIN)
AF:
0.427
AC:
22806
AN:
53392
Middle Eastern (MID)
AF:
0.518
AC:
2990
AN:
5768
European-Non Finnish (NFE)
AF:
0.430
AC:
478527
AN:
1111848
Other (OTH)
AF:
0.471
AC:
28446
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
21534
43069
64603
86138
107672
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14824
29648
44472
59296
74120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.536
AC:
81493
AN:
152160
Hom.:
23133
Cov.:
33
AF XY:
0.537
AC XY:
39967
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.715
AC:
29695
AN:
41510
American (AMR)
AF:
0.555
AC:
8480
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.383
AC:
1328
AN:
3466
East Asian (EAS)
AF:
0.701
AC:
3636
AN:
5186
South Asian (SAS)
AF:
0.558
AC:
2691
AN:
4824
European-Finnish (FIN)
AF:
0.433
AC:
4585
AN:
10596
Middle Eastern (MID)
AF:
0.497
AC:
146
AN:
294
European-Non Finnish (NFE)
AF:
0.434
AC:
29516
AN:
67972
Other (OTH)
AF:
0.531
AC:
1121
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1866
3733
5599
7466
9332
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
698
1396
2094
2792
3490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.466
Hom.:
27098
Bravo
AF:
0.551
Asia WGS
AF:
0.590
AC:
2050
AN:
3478
EpiCase
AF:
0.433
EpiControl
AF:
0.430

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
4
not provided (4)
-
-
1
Colorectal cancer, susceptibility to, 12 (1)
-
-
1
Colorectal cancer, susceptibility to, 12;C3554576:Facial dysmorphism-immunodeficiency-livedo-short stature syndrome;C5193036:Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (1)
-
-
1
Facial dysmorphism-immunodeficiency-livedo-short stature syndrome (1)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
-
1
Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
1.9
DANN
Benign
0.50
PhyloP100
-1.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=78/22
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5744857; hg19: chr12-133236000; COSMIC: COSV105207436; API